Skip to main content

Advertisement

Table 2 The relationship between differentiation score and other clinical characteristics

From: Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer

Characteristic Differentiation
Poor Moderate Well P value
Gender     0.107
 Male 49 (59.8%) 27 (32.9%) 6 (7.3%)  
 Female 41 (75.9%) 12 (22.2%) 1 (1.9%)  
Age     0.284
 ≤55 years 53 (71.6%) 17 (23.0%) 4 (5.4%)  
 >55 years 37 (59.7%) 22 (35.5%) 3 (4.8%)  
Chemotherapy regimen     0.310
 FOLFOX 24 (60.0%) 14 (35.0%) 2 (5.0%)  
 CapeOX 17 (65.4%) 9 (34.6%) 0 (0.0%)  
 TP 16 (76.2%) 5 (23.8%) 0 (0.0%)  
 Others 33 (67.3%) 11 (22.4%) 5 (10.2%)